-
-
-
-
-
-
-
Medincell: Videoconference and Publication of Half-year Financial Results, Tuesday, December 9, 2025
-
-
-
-
-
-
-
Medincell: Completion of the Pivotal Phase 3 Trial for Olanzapine LAI in Schizophrenia Conducted by Teva Pharmaceuticals
-
-
-
-
-
-
-
Medincell Publishes Its Consolidated Annual Financial Results
-
-
-
-
-
-
-
MedinCell Publishes Its Consolidated Half-year Financial Results
-
-
-
-
-
-
-
MedinCell Publishes Its Financial Results for the First Semester Of 2022-2023 (April - September 2022)
-
-
-
-
-
-
-
MedinCell publishes its financial results and activity report for the first half of 2021-2022 (April - September 2021)
-
-
-
-
-
-
-
MedinCell: Publication of the Activity Report and Financial Information for the First Half-Year (April - Sept. 2018)
1,210,937 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

